Plaques and tangles: Birthmarks of the aging soul
Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: A long-range point of view beyond 2020
Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines
Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins
The role of amyloid-beta in the regulation of memory
Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: Maintenance of brain iron homeostasis
TREM2 and the neuroimmunology of Alzheimer's disease
Immunotherapy for Alzheimer's disease
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Is synaptic loss a unique hallmark of Alzheimer's disease?
Tau-aggregation inhibitor therapy for Alzheimer's disease
New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
Brain metabolic dysfunction at the core of Alzheimer's disease
Novel lipid signaling pathways in Alzheimer's disease pathogenesis
Therapeutic implications of the prostaglandin pathway in Alzheimer's disease
Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): A paradigm worth exploring
Mitochondrial respiration as a target for neuroprotection and cognitive enhancement
Microglial dysfunction in brain aging and Alzheimer's disease
Statins more than cholesterol lowering agents in Alzheimer disease: Their pleiotropic functions as potential therapeutic targets
Building a pipeline to discover and validate novel therapeutic targets and lead compounds for Alzheimer's disease
Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Integrating the molecular and the population approaches to dementia research to help guide the future development of appropriate therapeutics
Future directions in Alzheimer's disease from risk factors to prevention
The complexities of the pathology–pathogenesis relationship in Alzheimer disease
The end of Alzheimer's disease—From biochemical pharmacology to ecopsychosociology: A personal perspective